Lexaria Bioscience Renews Contracts with Senior Management and Cancels Options Cannabis Investing News
Neon Therapeutics Completes Enrollment in Phase 1b NT-002 Clinical Trial for Metastatic Non-Small Cell Lung Cancer Pharmaceutical Investing
Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse Biotech Investing
Cannara Biotech Appoints, Former CEO of Apotex, Jack Kay as New Board Director Cannabis Investing News
MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee Cannabis Investing News
Life Science Big News Roundup: NanoSphere Products Approved for Sale in California; BriaCell Announces Clinical Trial Collaboration Agreement with Incyte Life Science Investing News
Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy Biotech Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
